MicrosensDx’s patented RapiPREP® Nucleic Acid Extraction for SARS-CoV-2 technology provides a rapid, sustainable, and scalable solution to extract nucleic acids from a variety of sample types.
The extraction is carried out by combining a proprietary magnetic bead-based solution with a buffer. No organic solvents, isopropanol or ethanol are required.
Extraction of the RNA from the sample takes less than 10 minutes.
It is also cost-effective as it does not require centrifugation; something necessary with traditional RNA extraction and which can lead to degradation of nucleic acids due to the shear forces involved.
Extraction with RapiPREP® Nucleic Acid Extraction for SARS-CoV-2 markedly increases the sensitivity of the subsequent LAMP or PCR result.
RapiPREP® Nucleic Acid Extraction for SARS-CoV-2can be used in a high-throughput format or in a close to patient setting, in a minimally equipped laboratory.
To get in touch with one of our team, call +44 (0)1223 626 252 or email email@example.com